CV
Publicaties op Oncologisch.com
Enfortumab vedotin plus pembrolizumab in untreated locally gevorderd or metastatic urothelial carcinoma: 2.5-year med...
Sacituzumab govitecan in gevorderd urothelial carcinoma: TROPiCS-04, a phase III gerandomiseerde trial.
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall surv...
Enfortumab vedotin versus chemotherapie bij urotheelcarcinoom: EV-301 24-maanden